Differentiation of vascular prostheses in dogs with serial tests of in vivo platelet reactivity.
Three different vascular prostheses (standard weight knitted Dacron, double velour knitted Dacron, and expanded polytetrafluoroethylene) were implanted in the aortas of dogs, and serial determinations of platelet survival and platelet serotonin were monitored at 12-week intervals for 1 year. Prostheses were then removed and luminal coverage with endothelialized neointima and production of prostacyclin were measured. Changes in platelet survival were correlated with changes in platelet serotonin, and both measurements reflected in vivo platelet reactivity with the vascular prostheses. These changes were unique for each type of prosthesis and were dependent upon physical characteristics and the rate and degree of coverage of the prosthetic surface with endothelialized neointima that produced prostacyclin. Prostheses that reduced platelet survival and platelet serotonin the least as shown by serial evaluation were found at harvest to be the most completely paved with nonthrombogenic neointima. In dogs, these techniques allow differentiation of vascular prostheses and provide a useful animal model for their evaluation.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D001013:Aorta, Thoracic / Q000378:metabolism / Q000601:surgery*; D001792:Blood Platelets / Q000378:metabolism / Q000502:physiology*; D001807:Blood Vessel Prosthesis; D002470:Cell Survival; D004285:Dogs; D004727:Endothelium / Q000378:metabolism; D011464:Epoprostenol / Q000378:metabolism; D005260:Female; D008297:Male; D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene; D012701:Serotonin / Q000097:blood
D011093:Polyethylene Terephthalates; D012701:Serotonin; D015121:6-Ketoprostaglandin F1 alpha; D011138:Polytetrafluoroethylene; D011464:Epoprostenol